[go: up one dir, main page]

BR9303990A - Compostos, processo para sua preparaçao, processo para purificaçao dos compostos, uso, processo para a preparaçao de medicamentos e medicamento obtido - Google Patents

Compostos, processo para sua preparaçao, processo para purificaçao dos compostos, uso, processo para a preparaçao de medicamentos e medicamento obtido

Info

Publication number
BR9303990A
BR9303990A BR9303990A BR9303990A BR9303990A BR 9303990 A BR9303990 A BR 9303990A BR 9303990 A BR9303990 A BR 9303990A BR 9303990 A BR9303990 A BR 9303990A BR 9303990 A BR9303990 A BR 9303990A
Authority
BR
Brazil
Prior art keywords
preparation
compounds
medicines
purification
medicine obtained
Prior art date
Application number
BR9303990A
Other languages
English (en)
Inventor
Gerhard Dr Noessner
Jurij Dr Stekar
Peter Dr Hilgard
Bernhard Dr Kutscher
Juergen Dr Engel
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of BR9303990A publication Critical patent/BR9303990A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66Arsenic compounds
    • C07F9/70Organo-arsenic compounds
    • C07F9/72Aliphatic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Cephalosporin Compounds (AREA)
BR9303990A 1992-10-01 1993-09-30 Compostos, processo para sua preparaçao, processo para purificaçao dos compostos, uso, processo para a preparaçao de medicamentos e medicamento obtido BR9303990A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4233044A DE4233044A1 (de) 1992-10-01 1992-10-01 Phospholipidderivate, die höhere Elemente der V. Hauptgruppe enthalten

Publications (1)

Publication Number Publication Date
BR9303990A true BR9303990A (pt) 1994-06-14

Family

ID=6469408

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9303990A BR9303990A (pt) 1992-10-01 1993-09-30 Compostos, processo para sua preparaçao, processo para purificaçao dos compostos, uso, processo para a preparaçao de medicamentos e medicamento obtido

Country Status (23)

Country Link
US (2) US5449798A (pt)
EP (1) EP0594999B1 (pt)
JP (1) JP3688304B2 (pt)
KR (1) KR100331367B1 (pt)
CN (1) CN1055697C (pt)
AT (1) ATE174030T1 (pt)
AU (1) AU661795B2 (pt)
BR (1) BR9303990A (pt)
CA (1) CA2107439C (pt)
DE (2) DE4233044A1 (pt)
DK (1) DK0594999T3 (pt)
EG (1) EG20258A (pt)
ES (1) ES2125935T3 (pt)
FI (1) FI111261B (pt)
GR (1) GR3029423T3 (pt)
HU (1) HU220593B1 (pt)
IL (1) IL107141A (pt)
MX (1) MX9306076A (pt)
NO (1) NO305911B1 (pt)
PH (1) PH29951A (pt)
RU (1) RU2126413C1 (pt)
UA (1) UA39163C2 (pt)
ZA (1) ZA937282B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP026997A0 (en) 1997-11-07 1997-12-04 Resmed Limited Administration of cpap treatment pressure in presence of apnea
WO2004062594A2 (en) * 2003-01-09 2004-07-29 Zeneus Pharma Limited Antineoplastic ether lipid compounds with modifications at the sn-3 carbon
KR101201935B1 (ko) * 2004-07-09 2012-11-16 바스큘라 바이오제닉스 리미티드 산화 인지질류의 개선된 제조 방법
PL1962862T3 (pl) 2005-12-19 2014-01-31 Aeterna Zentaris Gmbh Pochodne alkilofosfolipidów o ograniczonej cytotoksyczności i ich zastosowania

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177216A (en) * 1974-06-21 1979-12-04 The Dow Chemical Company Novel tributyl (2,5-dihydroxyphenyl)phosphonium hydroxide inner salts
US4177716A (en) * 1978-02-21 1979-12-11 Gerald J. Bowe Automatic energy saver and fire damper for exhaust systems
EP0050327B1 (de) * 1980-10-21 1984-06-20 Roche Diagnostics GmbH Neue schwefelhaltige Phospholipide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4534899A (en) * 1981-07-20 1985-08-13 Lipid Specialties, Inc. Synthetic phospholipid compounds
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
AT383130B (de) * 1984-05-15 1987-05-25 Chemie Linz Ag Verfahren zur herstellung von an c1 und c2 verschieden substituierten phosphatidylcholinen und phosphatidylethanolaminen ueber die neuen verbindungen 1-0-tritylglycerophosphocholin beziehungsweise (1-0,n-ditrityl)-glycerophosphoethanolamin
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
EP0916343A1 (de) * 1989-09-27 1999-05-19 ASTA Medica Aktiengesellschaft Verwendung von Alkylphosphorsäure-Verbindungen zur Bekämpfung von Psoriasis-Erkrankungen
DE3942933A1 (de) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh Verwendung von alkylphospholipiden als antivirale arzneimittel und neue phospholipid-derivate
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate

Also Published As

Publication number Publication date
EP0594999A1 (de) 1994-05-04
DK0594999T3 (da) 1999-08-16
MX9306076A (es) 1994-05-31
FI111261B (fi) 2003-06-30
DE4233044A1 (de) 1994-04-07
US5637577A (en) 1997-06-10
EP0594999B1 (de) 1998-12-02
CA2107439C (en) 2006-08-15
HUT65681A (en) 1994-07-28
GR3029423T3 (en) 1999-05-28
FI934297A0 (fi) 1993-09-30
DE59309182D1 (de) 1999-01-14
KR100331367B1 (ko) 2002-11-13
CN1055697C (zh) 2000-08-23
US5449798A (en) 1995-09-12
KR940009201A (ko) 1994-05-20
ATE174030T1 (de) 1998-12-15
HU220593B1 (hu) 2002-03-28
ZA937282B (en) 1994-04-25
NO305911B1 (no) 1999-08-16
UA39163C2 (uk) 2001-06-15
ES2125935T3 (es) 1999-03-16
PH29951A (en) 1996-09-16
EG20258A (en) 1998-05-31
NO933505D0 (no) 1993-09-30
JP3688304B2 (ja) 2005-08-24
IL107141A (en) 1998-01-04
NO933505L (no) 1994-04-05
IL107141A0 (en) 1993-12-28
FI934297L (fi) 1994-04-02
RU2126413C1 (ru) 1999-02-20
JPH06199876A (ja) 1994-07-19
AU4874793A (en) 1994-04-14
AU661795B2 (en) 1995-08-03
CA2107439A1 (en) 1994-04-02
CN1088583A (zh) 1994-06-29
HU9302772D0 (en) 1993-12-28

Similar Documents

Publication Publication Date Title
AU5022593A (en) Prodrugs, their preparation and use as pharmaceuticals
FI873509A7 (fi) Imidatsoliyhdisteet, menetelmä niiden valmistamiseksi ja näitä sisältävä farmaseuttinen seos.
FI941987A7 (fi) Uudet aminohappojohdannaiset, menetelmät niiden valmistamiseksi ja näi tä yhdisteitä sisältävät farmaseuttiset koostumukset
FI881978A0 (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI903215A7 (fi) Heteroaryyliamino- ja heteroaryylioksipyridiiniamiineja ja niihin liittyviä yhdisteitä, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkkeinä
FI942910L (fi) Uusia fosfonimeripihkahappojohdannaisia, menetelmä niiden valmistamiseksi ja näitä yhdisteitä sisältäviä lääkkeitä
PT86986A (pt) Substituted 9-amino-tetrahydroacridines and related compounds a process for their preparation and their use as medicaments
FI902734A7 (fi) 2-hydroksi-n-propyyliamiinit, näitä yhdisteitä sisältävät lääkeaineet ja menetelmä niiden valmistamiseksi
IL108071A0 (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
PT88225A (pt) Processo para a preparacao de formulacoes farmaceuticas contendo di-hidropiridinas
FI930974A7 (fi) Substituoidut aminofosonaattijohdannaiset, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
DE68925080D1 (de) FR-901154- und FR-901155-Derivate, Verfahren zu ihrer Herstellung
FI875719A7 (fi) Uudet alkaanisulfonanilidijohdokset, menetelmä niiden valmistamiseksi ja näitä sisältävät farmaseuttiset seokset.
BR9303990A (pt) Compostos, processo para sua preparaçao, processo para purificaçao dos compostos, uso, processo para a preparaçao de medicamentos e medicamento obtido
ATE63215T1 (de) Teilbare kapsel.
FI940031L (fi) Uusia 2-syaani-3-hydroksipropenamidijohdannaisia, menetelmä niiden valmistamiseksi, niiden käyttö lääkkeinä ja niitä sisältävät farmaseuttiset koostumukset
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
AU3019389A (en) 6-oxo-4,5-dihydro-pyridazine derivatives, a process for their preparation and medicaments containing these compounds
FI853866A7 (fi) 2-pyridiini-tioli-johdannaiset, menetelmäniiden valmistamiseksi ja niitä sisältävät farmaseuttiset yhdisteet.
FI960688L (fi) Substituoituja bentseenisulfonyyliureoita ja -tioureoita, menetelmä niiden valmistamiseksi ja näihin yhdisteisiin perustuvien farmaseuttisten valmisteiden käyttö sekä niitä sisältäviä lääkkeitä
FI802107A7 (fi) Aminotiadiatsolyyliyhdisteet, menetelmä niiden valmistamiseksi, niitä sisältävät farmaseuttiset valmisteet ja niiden käyttö.
PT84405B (pt) Processo para a preparacao de composicoes farmaceuticas contendo 2-alcoxi-n-(1-azabiciclo {2.2.2} octil-3-benzamida-n-oxidos apropriadas para controlar a emese provocada por drogas anti-cancro
PT83456B (pt) Processo para a preparacao de composicoes farmaceuticas de libertacao controlada da substancia activa
AU2273088A (en) Pharmaceutical products containing a 7-diphenylmethylene- bicycloheptane or 7-diphenylmethylenebicycloheptene derivative, the use of these compounds as medicaments, and new 7-diphenylmethylenebicycloheptanes and 7-diphenylmethylene-bicycloheptenes and processes for the preparation thereof
FI841293A7 (fi) Iminosulfonamidit ja menetelmä niiden valmistamiseksi, tällaisia yhdisteitä sisältävät farmaseuttiset valmisteet sekä niiden käyttö.

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal
B25A Requested transfer of rights approved

Free format text: ZENTARIS AG (DE)

B15G Petition not considered as such [chapter 15.7 patent gazette]

Free format text: DESCONHECIDA A PETICAO DE TRANSFERENCIA E ALTERACAO DE NOME NO 020050014799/RJ DE 03/03/2005, POR FALTA DE FUNDAMENTACAO LEGAL, JA QUE O PEDIDO ENCONTRA-SE INDEFERIDO.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]